Targeted therapy of RET fusion-positive non-small cell lung cancer.

Shen, Zixiong; Qiu, Binxu; Li, Lin; Yang, Bo; Li, Guanghu

Shen, Zixiong; Qiu, Binxu; Li, Lin; Yang, Bo; Li, Guanghu.

Afiliación

Shen Z; Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China.
Qiu B; Department of Gastrointestinal Surgery, The First Hospital of Jilin University, Changchun, China.
Li L; Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China.
Yang B; Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China.
Li G; Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China.

Front Oncol ; 12: 1033484, 2022.

Article en En | MEDLINE | ID: mdl-36582799

Palabras clave

RET fusion; RET gene; cancer biology; non-small cell lung cancer (NSCLC); targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google